Clinical management of eosinophilic gastrointestinal disorders

Rothenberg ME: Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2004, 113:11–28; quiz 29. Teitelbaum JE, Fox VL, Twarog FJ, et al.: Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002, 122:1216–1225. Justinich C, Katz A, Gurbindo C, et al.: Elemental diet improves steroid-dependent eosinophilic gastroenteritis and reverses growth failure. J Pediatr Gastroenterol Nutr 1996, 23:81–85. Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA: Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 2003, 98:777–782. Prussin C, James SP, Huber MM, et al.: Pilot study of anti-IL-5 in eosinophilic gastroenteritis. J Allergy Clin Immunol 2003, 111:S275. Garrett JK, Jameson SC, Thomson B, et al.: Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004, 113:115–119. Lee M, Hodges WG, Huggins TL, Lee FL: Eosinophilic gastroenteritis. South Med J 1996, 89:189–194. Schneider DL, Barrett-Connor EL: Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density. Arch Intern Med 1997, 157:1241–1245. Reid IR, Brown JP, Burckhardt P, et al.: Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 2002, 346:653–661.